BeerDaily.com Dispensary Manufacturing Contests Media Kit Editor@IndicaDaily.com SativaDaily.com
 

Cannformatics Unlocks Medical Cannabis Mechanism of Action in Children with Autism Spectrum Disorder


Chosen by Staff Editors on 30-MAR-22

Cannformatics, an early-stage biotechnology startup, announced that it identified 22 new potential lipid-based Cannabis-Responsive™ biomarkers in the saliva of children with autism spectrum disorder (ASD).

All 22 biomarkers shifted toward the physiological range of typically developing children following successful medical cannabis treatment. These biomarkers include central nervous system lipids that are primarily associated with cellular activity in the brain indicating medical cannabis' potential to impact neuron function in children with ASD. These discoveries continue the company's progress towards launching a personalized medicine service as a resource to healthcare providers and patients wanting to use cannabinoid-based medicines and products to treat complex medical conditions.

The company published its findings in the journal Cannabis and Cannabinoid Research in a paper titled, "The potential of salivary lipid-based Cannabis-Responsive biomarkers to evaluate medical cannabis treatment in children with ASD." This paper is the second paper to come from the company's ASD Pilot study. The first paper which was published in December 2021 established Cannabis-Responsive biomarkers as a universal tool for measuring medical cannabis impact. Together the two papers demonstrate the potential for saliva-based Cannabis-Responsive biomarkers to be a tool for both clinicians treating patients with medical cannabis and life science companies developing next generation cannabinoid-based medicines and applications.

"By unlocking medical cannabis' mechanism of action, we demonstrate that Cannabis-Responsive biomarkers can provide life science companies and clinicians with new tools for understanding the role of cannabis in maintaining homeostasis of the central nervous system in children with ASD. This study also opens new opportunities to evaluate medical cannabis treatment in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and ALS, in which some of these potential lipid-based Cannabis-Responsive biomarkers are known to play a role", said Itzhak Kurek, PhD, CEO and cofounder of Cannformatics. "We are now in position to the raise the capital needed to launch the ASD service platform and expand into neurodegenerative diseases."

"The publishing of this second paper is a pivotal moment for Cannformatics as it fully validates our technology and clearly positions us as the biotechnology leader in medical cannabis treatment," said Kenneth Epstein Chief Commercial Officer and cofounder of Cannformatics. "We continue to be grateful to the children and families that participated in the study as well as our sponsors Canniatric and Whole Plant Access for Autism. The findings from this study went well beyond our expectations."

About Cannformatics:

Cannformatics is an early-stage biotechnology startup focused on the development of Cannabis-Responsive™ biomarkers found in saliva for personalized medical cannabis treatment, product development and other applications. Cannformatics is headquartered in San Francisco, CA. Investors interested in learning more about the Series A investment opportunity please email partner@cannformatics.com. Follow us on Twitter @cannformatics.


For Illustrative Purposes Only.

Related URL:https://www.cannformatics.com


This article is from the Testing Lab basket.
(Important there are many baskets: Basketball, Basketcase, Basket the Magnificant, Utility Basket, A Woven Basket ... in our case a basket is just a basket. Go Figure!)


Next Story


Support Our Sponsors


 


RED ALERT! Privacy Policy: WE DO NOT TRACK. Frankly, we do not give a hoot. What does that mean? Well, when you look for a Marijuana Dispensary you have to scroll to your own city, instead of a blue dot on a map. Only native html ads are on this site. No network ads. No cookie bunnies. None. If you really miss Big Brother helping you browse the web, best you not be here. I know. stoners do not like working? Ha! So, again, we have a 100% no tracking policy. Questions? Email Editor@IndicaDaily.com. The content herein, unless otherwise known to be public domain, are Copyright 2018-2021 The Daily Network LLC. All websites are published in United States of America and are solely subject to US law and governed by Fair Use principals for news reporting and research purposes. All Goverment sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by The Daily Network LLC on any Web page published or hosted by The Daily Network LLC.
BeerDaily.com Dispensary Manufacturing Contests Media Kit Editor@IndicaDaily.com SativaDaily.com